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ABSTRACT We use discrete event stochastic simulations to characterize the parameter space of a model of icosahedral viral
capsid assembly as functions of monomer-monomer binding rates. The simulations reveal a parameter space characterized by
three major assembly mechanisms, a standard nucleation-limited monomer-accretion pathway and two distinct hierarchical
assembly pathways, as well as unproductive regions characterized by kinetically trapped species. Much of the productive
parameter space also consists of border regions between these domains where hybrid pathways are likely to operate. A simpler
octamer system studied for comparison reveals three analogous pathways, but is characterized by much lesser sensitivity to
parameter variations in contrast to the sharp changes visible in the icosahedral model. The model suggests that modest
changes in assembly conditions, consistent with expected differences between in vitro and in vivo assembly environments,
could produce substantial shifts in assembly pathways. These results suggest that we must be cautious in drawing conclusions
about in vivo capsid self-assembly dynamics from theoretical or in vitro models, as the nature of the basic assembly
mechanisms accessible to a system can substantially differ between simple and complex model systems, between theoretical
models and simulation results, and between in vitro and in vivo assembly conditions.
INTRODUCTION
Self-assembly, a process by which collections of molecules
spontaneously assemble into some structure or molecular
machine under appropriate conditions, is an essential process
for many of the key activities of living cells. These include
the formation of protein and nucleic acid complexes neces-
sary to protein, RNA, and DNA synthesis and degradation as
well as pathological conditions such as the formation of
prions and viral particles (1–3). An accurate understanding
of complicated self-assembly reactions is therefore an im-
portant step in advancing the ﬁeld of systems biology, which
aims to build predictive models of the interactions of large
numbers of components in living systems (4). Among the
many examples of extremely sophisticated self-assembly in
biology, virus capsid assembly has emerged as perhaps the
most important model system for understanding complex
self-assembly in general, in large part because of its relative
experimental tractability and because the high symmetry of
the structures makes them more amenable to theoretical
analysis than are more heterogeneous systems. Nonetheless,
our knowledge of capsid assembly and other complex self-
assembly systems remains limited by the experimental
challenges in directly observing rapid reactions on nanome-
ter scales, particularly under in vivo conditions. Simulation
methods have thus been essential to developing an under-
standing of the detailed dynamics of these systems.
Some of the key open questions about virus capsid
assembly concern the nature of assembly pathways. Exper-
imental examination of in vitro assembly systems suggests a
great deal of diversity in assembly pathways among viruses.
For example, the T ¼ 7 phage P22 shows evidence of
assembly through nucleation of a pentamer followed by
accretion of coat protein monomers (5). HK97 (6), another
T ¼ 7 phage, and the human pathogen papillomavirus (7)
both appear to assemble in a process involving an initial
formation of capsomers (pentameric or hexameric compo-
nents of the capsid), which then assemble into icosahedral
shells. We deﬁne such an assembly process, in which capsid
assembly proceeds through an initial aggregation reaction of
coat monomers into a deﬁned oligomer that then acts as the
basic subunit for nucleation-limited capsid growth, as a
‘‘hierarchical assembly process’’. This deﬁnition is in con-
trast to the oligomer-oligomer binding pathways that were
found in prior simulation work (8,9) to provide a partial res-
cue pathway from kinetic trapping under conditions where
nucleation-limited growth breaks down due to excessively
high rate or concentration. Hepatitis B virus (HBV) (10)
and cowpea chlorotic mottle virus (CCMV) (11) assemble
through a different hierarchical process in which coat mono-
mers ﬁrst accumulate into dimers, then these dimers as-
semble via a nucleation-limited growth process involving a
trimer-of-dimers nucleus. This diversity of assembly mech-
anisms raises several questions. Why have different assem-
bly pathways evolved, even for viruses with superﬁcially
very similar ﬁnal assembled geometries? Are there advan-
tages or disadvantages to one pathway over another or is the
choice simply arbitrary? How is the selection of pathways
controlled at the level of protein-protein binding interac-
tions? The answers to these questions could have important
implications for human medicine, where attempts are being
made to treat viral diseases by disrupting key steps in the
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assembly (12–14); for nanotechnology, where principles
underlying virus capsid assembly and other complex bio-
logical assemblies are likely to prove valuable in learning
how to design artiﬁcial self-assembly systems (15,16); and
for basic research into the function and evolution of viruses.
Theoretical and simulation studies are proving crucial in
interpreting these experimental results and gaining some
understanding of the nature of assembly pathways in icosa-
hedral capsids. Endres et al. (17) have applied a master
equation approach, showing in simpliﬁed capsid models that a
small number of critical intermediates can account for almost
all of the pathways in a model system. A similar master
equation technique was used by the same group to distinguish
between different models of overall reaction pathways for
hepatitis B virus assembly (10). This approach was general-
ized by Keef et al. (18) to study possible pathways and critical
intermediates for the simian virus 40 (SV40) capsid and by
Endres and Zlotnick (17) to provide general tools for
interpreting experimental data on assembly kinetics to study
overall pathways. In more recent work, our group has used
stochastic simulations to study conditions under which these
simplifying assumptions might break down. These studies
found that high concentrations or conditions promoting high
binding rate can bias the favored assembly pathways,
promoting use of oligomer/oligomer interactions neglected
under more simpliﬁed models (8). Furthermore, these effects
become substantially more pronounced as we move from
simpler to more complex capsid models (19). Coarse-grained
molecular-dynamics-like models of capsid assembly have also
proven useful for examining the effects of several parameters,
such as solution temperature, concentration, and binding
energy, on models of capsid assembly (1,20).
In this study, we apply stochastic discrete event simulations
of icosahedral capsid assembly to attempt to answer some of
the open questions about the nature of the assembly parameter
space of complex self-assembly systems. Like Schwartz et al.
(1), Endres and Zlotnick (17), Keef et al. (18), and Nguyen
et al. (20), we are interested in studying the ‘‘phase space’’ of
a complex assembly system as a whole as a function of its
low-level binding interactions. We wish to understand what
kinds of assembly pathways are accessible, what advantages
or disadvantages they might have relative to one another, and
how parameter variations produce transitions among them.
For this purpose, we employ stochastic discrete event
simulation, a simulation type that implements a kinetically
correct model of all possible assembly pathways implied by a
given set of binding rules, speciﬁcally excluding those
pathways that would involve binding interactions that do
not conform exactly to the binding rules. By kinetically
correct, we mean that all possible pathways in the model will
be sampled with probability proportional to their overall rates,
provided the subunit-subunit binding rates are valid. The
approach thus has the advantage of allowing a single
simulation system to be used for a broad range of parameter
values, regardless of which dominant pathways or combina-
tions of pathways any particular parameter set produces. We
use this method to explore accessible regions of the parameter
space deﬁned by varying two rate constants, comparing
different points in space by their overall rates and yields, and
by their intermediate distributions over time. To our knowl-
edge, this is the ﬁrst attempt to elucidate the space of assembly
pathways as functions of coat-coat binding rates for a model
of capsid assembly. We perform analogous experiments on
a simpler octamer system to understand how the larger
icosahedral system might behave in ways that would be
unexpected from experience with simpler model systems.
These results provide a basis for understanding the diversity of
pathways available in a complex self-assembly system and the
means by which transitions between them can be controlled.
METHODS
Simulator design
Our simulations are based on a previously developed simulation tool (21) for
coarse-grained simulation of complex self-assembly systems. The tool
implements stochastic discrete event simulations using the model of
Gillespie (22), a representation of stochastic reaction chemistry that is
based on a continuous time Markov model (23) of the possible reaction
trajectories of a system with ﬁnite numbers of intermediate species. The
Gillespie model is implemented with a queue-based algorithm for fast,
memory-efﬁcient simulation of systems with large numbers of distinct
intermediates (24). The simulator speciﬁes model systems with a local rules
representation (1,25), in which each assembly subunit is characterized by a
set of binding sites with allowed neighbor sites and associated reaction rate
constants. These subunit rules implicitly specify all of the structures and
reactions that are possible in the system. To correct for the greatly reduced
dissociation rate we would expect for multiply bound subunits, the simulator
was run with an option disallowing dissociation of any subunit held in an
assembly by multiple binding interactions unless all but one of that subunit’s
neighbors ﬁrst dissociates from the assembly. This option has the effect of
treating ‘‘loops’’ of subunits as inﬁnitely stable over the time course of a
simulation. The reader is referred to Zhang et al. (21) for details on the
simulator implementation.
The simulator can optionally institute a correction for diffusion rates of
oligomer species based on that of Lok and Brent (26). When this correction is
used, the rate of a given binding interaction between two oligomers of size N1





Compared to the model without such a correction, this correction would
be expected to yield a slower overall binding rate, yet yield more accurate
binding rates for oligomer-oligomer interactions in a diffusion-limited sys-
tem. The correction is not used for the majority of the simulations described
below, but is enabled for a series of comparative simulations to determine
the degree to which altered diffusion rates would affect our results for a
diffusion-limited system.
Model systems
Two model systems were applied in this study. The study is primarily
concerned with capsid assembly and relies on a 60-mer icosahedral capsid
model for this purpose. The icosahedron was chosen because it is the
simplest representation of spherical virus capsid assembly at the monomer
level. Similar icosahedral model systems have been used in several prior
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simulation studies of capsid assembly (1,19,20,27,28). Previous studies by
our group (8,19) have suggested several important qualitative differences in
assembly behavior between such complex models and simpler, more ex-
perimentally tractable systems. To learn whether these complexity effects
are also important to pathway selection, we also modeled a simpler
octameric system. Although this latter system is too simple to be a realistic
model of virus capsid assembly, it is sufﬁciently complex to exhibit several
possible assembly mechanisms analogous to those found in the capsid
models. Fig. 1 shows screen snapshots from these two model systems
alongside the local rules specifying interactions between two binding sites of
two different monomers. Fig. 1, a–d, show the complete octamer, two
important intermediates in its assembly, and the local rules deﬁning particle
interactions in the system. The rules establish three binding interactions at
90 angles to one another. Two of them (colored green and yellow) yield an
asymmetric binding interaction that produces square ‘‘capsomer’’ interme-
diates. We refer to these as the ‘‘intracapsomeric’’ bonds by analogy to the
binding interactions producing pentameric capsomer substructures in
icosahedral capsids. The other interactions (colored blue) form perpendic-
ularly to the square capsomers through what we call ‘‘intercapsomeric’’
binding. To distinguish the tetrameric square (Fig. 1 c) involving two
intercapsomeric and two intracapsomeric binding interactions from the
capsomer (Fig. 1 b) formed only through four intracapsomer binding
interactions, we refer to the former structure as a heterogeneous tetramer and
the latter as a homogeneous tetramer. Two homogeneous tetramers can bind
to one another by their four free binding sites each to create the full cube-
shaped octamer. Fig. 1, e–h, show screen snapshots for the icosahedron and
capsomer and trimer-of-dimer intermediates and the local rule deﬁning the
monomer binding interactions. A pair of asymmetric intracapsomer binding
sites at 108 angles to one another produce a pentameric capsomer structure
(Fig. 1 f). Intercapsomer binding sites bind symmetrically to one another to
link 12 pentamers into the complete icosahedron.
Experiments
Each system is parameterized by two forward rate constants and two reverse
rate constants for the two binding interaction types. We denote these four
rate constants by ka1 (intracapsomer forward rate constant), ka (intra-
capsomer reverse rate constant), kr1 (intercapsomer forward rate constant),
and kr (intercapsomer reverse rate constant). We ﬁxed a constant rate of 10
3
(in arbitrary units) for both ka and kr in our two modeling systems and
varied the two forward rates independently for each of the two systems. For
the octameric system, we varied both ka1 and kr1 from 10
3 to 105 in
10-fold increments. For the icosahedral system, we varied ka1 over the range
of 102–105 and kr1 over the range of 10
4–103 in 10-fold increments. Each
simulation run was initialized with 100N subunits, where N is the number of
monomers in the complete structure (eight for octamer, 60 for icosahedron).
Given such initial conditions, a maximum number of 100 complete struc-
tures could be achieved for each model system.
Each simulated assembly reaction was run until a pseudoequilibrium was
achieved. Pseudoequilibrium was manually veriﬁed by determining whether
all well-populated reactant species had reached stable counts in the
simulation. We recorded the ﬁnal yield (Y) of assembled complete structures
in each system. We also recorded the time at which the amount of complete
assembled structures reached Y/2. This time, which we call T50, is used as a
measure of the overall assembly rate. We also recorded the time courses of
several important intermediate reactant species: 2-mer, 4-mer, and 8-mer
intermediates for the octamer system and 2-mer, 5-mer, and 60-mer for the
icosahedral system. These distributions are used to identify the pathways
involved in each assembly reaction. These simulations were repeated with
the diffusion rate correction described under ‘‘Simulator design’’ above.
RESULTS AND ANALYSIS
Fig. 2 shows the ﬁnal yield (Y) of complete products
(octamer or icosahedron) at equilibrium and the time to reach
half of this yield (T50) for each of the systems as functions of
the inter- and intracapsomer binding rates. Fig. 2, a and c,
depicts the yields and times for the octamer model. The
ﬁgure displays several distinct regions of interest. When both
binding rates are high (fronts of the ﬁgures), we observe a
region of low yield, consistent with prior evidence of high
kinetic trapping in the presence of high binding afﬁnity
(8,19). Although yield is low in this region, the overall
assembly rate is rapid, as implied by the low T50 in the front
region of Fig. 2 c. Conversely, when both rates are low
(backs of the ﬁgures), we observe nearly 100% yield but
longer assembly time, as expected (8). Two distinct ﬂat
regions of high yield are observable in the left and right
portions of the ﬁgures, with the right side corresponding to
a low rate of intracapsomer binding but a high rate of
intercapsomer binding and the left side corresponding to a
high rate of intracapsomer binding but a low rate of
intercapsomer binding. The slower of the two binding rates
FIGURE 1 Model systems, key intermedi-
ates, and the local rules that produce them. The
top row corresponds to the octamer system and
the bottom row to the icosahedron system. (a)
Complete octamer. (b) Homogeneous tetramer
(capsomer) intermediate. (c) Heterogeneous
tetramer intermediate. (d) Local rule describing
the coat protein interactions in the octamer. The
yellow and green arrows represent the asym-
metric intracapsomer binding interactions and
the blue arrows represent the symmetric inter-
capsomer interactions. (e) Complete icosahe-
dron. (f) Pentamer (capsomer) intermediate. (g)
Hexamer (trimer-of-dimers) intermediate. (h)
Local rule describing the coat protein interac-
tions in the icosahedron. The yellow and green
arrows represent the asymmetric intracapsomer
binding interactions and the blue arrows repre-
sent the symmetric intercapsomer interactions.
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is limiting in each of these domains, because assembly yield
and T50 are insensitive to further increases in the higher rate.
Yield appears essentially constant within either the left or
right region over the parameter ranges examined, although
the left region has a noticeably higher yield than the right.
There is a continuous transition between these two regions
through a third region of high yield where rates are similar
for the two interaction types (back of the ﬁgures). Rate and
yield are sensitive to changes in either parameter within this
region. There is a gradual decline in yield and T50 as
parameters increase toward the fronts of the ﬁgures.
We can partially interpret this ﬁgure in terms of major
pathways we would expect at different points in the
parameter space. Fig. 3 a illustrates the pathways we would
anticipate for the octamer assembly system. Where inter-
capsomer rates are much higher than intracapsomer rates, we
would expect a hierarchical assembly mechanism, in which
we rapidly accumulate dimers made by intercapsomer bonds
before assembling octamers from the dimers through a
second-order tetramer nucleation followed by ﬁrst-order
elongation. We call this a type I hierarchical assembly. This
pathway corresponds to the right-side plateau region of Fig.
2, a and c. Since rapidly produced dimers are the building
blocks for the formation of octamers, some population of
hexamers would be formed and would continue to exist at
pseudoequilibrium when no more dimers are available to
further extend them to octamers. These hexamers would then
become kinetically trapped, causing the observed lower
octamer yield in that parameter domain. Where intra-
capsomer rates are higher, we would expect rapid accumu-
lation of tetrameric ‘‘capsomers’’ in a fourth-order reaction,
followed by accumulation of pairs of tetramers into octamers
in a single additional step. We call this a type II hierarchical
assembly. It would correspond to the left-side plateau region
of Fig. 2, a and c. When rates are approximately balanced,
we would expect a standard single-stage nucleation-limited
FIGURE 2 Changes of assembly yields (a and b) and assembly time needed to reach half the equilibrium level (T50) (c and d) with intracapsomer and
intercapsomer binding rate constants. A ﬁxed breaking rate constant of 1000 is used across all the simulation experiments. (a) Yield of ﬁnal assembled 8-mer
(cube) structures for the octamer model. (b) Yield of ﬁnal assembled 60-mer structures (icosahedron) for the capsid model. (c) T50 for the octamer model. (d)
T50 for the icosahedral capsid model.
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assembly, where fourth-order nucleation of tetramers is
followed by a second-order elongation through monomers.
The nuclei could be capsomers or heterogeneous tetramers.
We call this nonhierarchical mechanism a type III assembly.
It would correspond to the region toward the middle of the
plots. Despite their distinct assembly pathways, both type II
and type III domains are capable of reaching the same end
state of nearly complete conversion of monomers into
octamers. The type II assembly provides a more efﬁcient
path to that end state, however. The type III assembly is also
susceptible to kinetic trapping when both binding rates are
high. Such kinetic trapping has been observed in many prior
simulation and experimental studies of such systems (5,8).
Note, though, that this pathway analysis is a signiﬁcant
oversimpliﬁcation. It can approximately explain the behavior
of the system at the extremes of rates in terms of three
discrete mechanisms. The empirical data, though, shows a
smooth transition in yield and rate as we move between these
domains. Much of the parameter space thus appears to be
occupied by regions where combinations of the three major
assembly types or hybrid reactions not contained in any of
them would be expected.
Fig. 2, b and d, depict the variation in yield and T50 for the
icosahedron. As with Fig. 2, a and c, we can identify three
productive assembly regions in the parameter space: the type
I region (back right), the type II region (back left), and the
type III region (back center). Fig. 2 b shows high yield areas
all along the back of the ﬁgure, corresponding to low rate in
either parameter. High intercapsomer rates relative to intra-
capsomer rates result in a region of moderate yield at the
back right of the ﬁgures. High intracapsomer rates relative to
intercapsomer rates results in a region of high yield at the
back left. Although these features are qualitatively similar to
those observed for the octamer system, there are some
notable contrasts. The icosahedron shows a precipitous drop
off each region of high yield as the limiting rate increases.
FIGURE 3 Predicted pathway do-
mains for the two model systems.
Each system is predicted to have three
major pathways: two distinct hierarchi-
cal pathways (types I and II) and one
nonhierarchical pathway exhibiting
classic nucleation-limited growth (type
III). (a) Octamer pathways. (b) Icosa-
hedron pathways.
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The octamer, by contrast, shows only gradual decreases in
yield. The right region for the icosahedron achieves maxi-
mum yield at a noticeably higher overall assembly rate than
is possible in the left region. The left region is signiﬁcantly
broader and subject to a more gradual decrease in yield and
increase in rate with increasing intercapsomer binding rate.
For example, the right region drops from nearly 100% yield
to zero yield over approximately a 100-fold change in intra-
capsomer rate in contrast to the ;10,000-fold change in in-
tercapsome rate needed to cause a similar shift in yield in
the left region. The right region thus appears to be the
optimal domain for maximizing the rate of peak yield under
highly controlled conditions, whereas the left region may be
superior at achieving a robustly high yield under unpredict-
able conditions. There is once again a smooth transition
between these regions through an intermediate region where
the two binding rates are roughly proportional. Rates and
yields are sensitive to both binding rates within this middle
region, but largely insensitive to the larger of the two rates
beyond it.
We can again interpret the ﬁgure in terms of three likely
binding pathways. Fig. 3 b shows three pathways expected
for the icosahedron system. Type I again corresponds to
rapid intercapsomer binding, resulting in production of
dimers that then assemble into complete shells through the
nucleation of heterogeneous hexamers. Type II is again a
hierarchical mechanism produced by rapid intracapsomer
binding. For the icosahedron, though, type II assembly
proceeds by aggregation into pentamers then to a nucleation-
limited growth through a trimer-of-pentamers nucleus. The
asymmetry in sensitivity to rate change between these
regions can be largely explained by the differences in the
number of required elongation steps after the aggregation
stage. Both regions have third-order nucleation rates after
aggregation, but the type II has many fewer elongation steps
than the type I because it grows by pentamers rather than
dimers. The long elongation phase would make the type I
domain relatively less resistant to kinetic trapping and rate
changes in the presence of small parameter variations. A
nonhierarchical type III region is again predicted where there
is a rough balance of rates. In this case, the nonhierarchi-
cal nucleation-limited assembly would be expected to
proceed by slow pentamer nucleation followed by monomer
accretion. All three regions would be expected to exhibit
nucleation-limited growth after the aggregation reaction,
making them vulnerable to kinetic trapping when binding
rates are high. The trapped intermediate species may, how-
ever, differ between the three domains. The higher orders of
most of the key assembly steps for icosahedron relative to
octamer would explain the overall greater sensitivity of
icosahedron rates and yields to small parameter variations.
Note that these three pathway types are a result of the par-
ticular pattern of binding interactions used in our capsid
model. A model allowing for more types of binding inter-
actions with independent rates, as in Hagan and Chandler
(9), could potentially open up additional pathway types not
accessible to our two-parameter model.
To validate our interpretation of the rate and yield plots in
terms of assembly mechanism, we conducted an additional
analysis of intermediate distributions at three selected points
in parameter space for each system. Fig. 4 shows curves of
selected intermediate distributions over time for one point in
parameter space believed to be representative of each of the
three pathway domains for each system. The product of yield
of each species at any time point and with its size is used here
to quantify its distribution. The speciﬁc points in parameter
space chosen are marked on Fig. 5 by capital letters A–F.
Boundaries between the assembly domains were manually
marked on Fig. 5 by looking for points at which the overall
assembly rate becomes insensitive to further increases in the
rate of the aggregation reaction. Fig. 4, a–c, show results for
the octamer system, where we monitored time distributions
of dimers, tetramers, and octamers. Fig. 4 a shows the point
ka1 ¼ 102, kr1 ¼ 10, believed to lie in the type I domain
and marked by the letter A in Fig. 5 a. As expected, the graph
shows a rapid production of symmetric dimers, which are
slowly consumed to assemble heterogeneous tetramers and
octamers. Fig. 4 b shows the point ka1 ¼ 10, kr1 ¼ 102,
believed to lie in the type II domain and marked by the letter
B in Fig. 5 a. It shows a more pronounced early spike of
tetrameric capsomers, which is accompanied by a lower peak
of dimers. These early dimers are believed to be asymmetric
dimers necessary for the early production of capsomers.
These dimers are rapidly consumed into capsomers, which
are then converted into octamers. Since only two capsomers
are required to form an octamer, there is no possibility of
kinetic trapping with this mechanism. Fig. 4 c shows the
point ka1 ¼ 102, kr1 ¼ 102, believed to lie in the type III
nonhierarchical domain and marked by the letter C on Fig. 5
a. This point shows minimal transient accumulation of either
dimers or tetramers, consistent with the nucleation-limited
assembly by monomer accretion predicted for a type III
assembly.
Fig. 4, d–f, show the time distributions for the icosahedron
system, where we monitored distributions of dimers, penta-
mers, and icosahedra (60 mers) over time. Fig. 4 d shows the
point ka1 ¼ 102, kr1 ¼ 10, believed to lie in the type I
domain and marked by the letter D on Fig. 5 b. As expected,
the graph shows rapid formation of a high concentration of
dimers followed by their gradual decrease as they assemble
into 60 mers. There is negligible transient accumulation of
pentamers. These observations are consistent with the
predicted type I assembly pathway. Fig. 4 e shows the point
ka1¼ 1, kr1¼ 102, believed to lie in the type II domain and
marked by the letter E on Fig. 5 b. It shows an early peak of
pentamers, although also a small, short-lived peak of dimers.
The pentamers are consumed as the reaction progresses,
coincident with the appearance of 60mers. These observations
are consistent with the predicted type II pathway. Fig. 4 f
shows the point ka1 ¼ 101, kr1 ¼ 101, believed to lie in
Parameter Space of Capsid Self-Assembly 777
Biophysical Journal 94(3) 772–783
the type III nonhierarchical domain and marked by the letter
F on Fig. 5 b. Although this point does exhibit some early
production of both dimers and pentamers, neither accounts
for more than a small fraction of the total monomers pre-
sent. This lack of well-populated intermediates is consistent
with the expected type III pathway, although possibly with
limited use of type I and type II reactions.
We ﬁnally sought to determine the degree to which
accounting for altered diffusion rates might affect the results
of our model. This correction would tend to yield more
accurate results for a system in which binding rate is
diffusion limited. Fig. 6, a–f, shows the results of simulations
conducted with identical parameters to those of Fig. 4, a–f,
but with the diffusion rate correction option described in
Methods enabled. Intermediate distributions over time show
that the three pathway types are all conserved at all six
parameter values examined, although there are small quan-
titative differences in the curves. Assembly tends to be
FIGURE 4 Weighted intermediate species distributions over time for regions of interest. (a) Octamer simulation for ka1¼ 102, kr1 ¼ 10, belonging to the
type I region. (b) Octamer simulation for ka1¼ 10, kr1¼ 102, belonging to the type II region. (c) Octamer simulation for ka1¼ 102, kr1¼ 102, belonging
to the type III region. (d) Icosahedron simulation for ka1¼ 102, kr1¼ 10, belonging to the type I region. (e) Icosahedron simulation for ka1¼ 1, kr1¼ 102,
belonging to the type II region. (f) Icosahedron simulation for ka1 ¼ 101, kr1 ¼ 101, belonging to the type III region.
FIGURE 5 Phase diagrams mapping
the predicted regions of assembly to plots
of T50. Darker intensities correspond to
shorter times to assembly or to regions in
which no productive assembly occurs.
The slopes of the boundary lines are
based on the orders of the aggregation
events for the two hierarchical domains
whereas the exact positions of the lines
are based on visual identiﬁcation of the
region for which further change in the
higher rate produces negligible overall
increases in reaction rate. Consensus
parameter values from capsid assembly
estimates in the literature are marked
assuming a 10-mM concentration typical
for an in vitro system (circles) or assum-
ing 500 mM concentration more likely to be representative in vivo (squares). Letters A–Fmark points in the parameter domain at which intermediate distributions
over time are surveyed in Fig. 4. (a) Octamer system. (b) Icosahedral system.
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slightly slower with the correction but also to reach a slightly
ﬁnal higher yield at equilibrium. The correction therefore
appears to produce some modest quantitative effects but to
yield no signiﬁcant qualitative change in any of the three
pathway regions for either model system.
DISCUSSION
We have used stochastic discrete assembly simulations to
characterize the space of assembly pathways for simple
models of spherical virus capsid assembly. The simulations
reveal three major pathway domains capable of producing
nontrivial amounts of complete structures for each model
system. One exhibits a nonhierarchical nucleation-limited
assembly corresponding to slow formation of a nucleus
followed by elongation by monomer addition. The others
correspond to two hierarchical assembly mechanisms for
which growth is preceded by aggregation into a multimer
that acts as the principle unit of assembly. Although pathway
phase diagrams are qualitatively similar between the two
systems, the icosahedral system is characterized by a
comparatively smaller productive parameter space and a
much greater sensitivity to parameter changes in moving
between domains or between productive and kinetically
trapped regions of a given domain. Although the abstraction
of discrete pathway domains is useful for understanding the
systems, it is important to note that the boundaries between
them are largely an artiﬁcial construct. The quantitative
results show smooth transitions in overall assembly rates and
yields as we move across the boundaries, suggesting that
much of the productive parameter space likely represents
mixtures of the dominant pathways and hybrid pathways
accessible to the simulator but difﬁcult to model theoreti-
cally.
One application of this work is to explore how we might
alter binding rates to improve a self-assembly system by any
given measure, an important question for understanding
selective pressures on viral evolution and for using viral
capsids as models for self-assembling nanotechnology. We
could similarly ask how we might best interfere with an
assembly system to disrupt normal growth. We can adopt the
somewhat imprecise deﬁnition that a ‘‘good’’ system is one
that leads to simultaneous high yield and short assembly
time. In the octamer case, there then appears to be a slight
advantage to the type II domain. The type III pathway can
also achieve nearly complete yield, but at lower rates than the
type II. The type I pathway is a poor choice by this criterion
because it cannot achieve a peak yield for any parameters
and generally has lower yield for a given rate than either type
II or type III. The type II domain accomplishes this by
FIGURE 6 Weighted intermediate species distributions over time for regions of interest with the simulator’s diffusion rate correction option enabled. (a)
Octamer simulation for ka1¼ 102, kr1¼ 10, belonging to the type I region. (b) Octamer simulation for ka1¼ 10, kr1¼ 102, belonging to the type II region.
(c) Octamer simulation for ka1¼ 102, kr1¼ 102, belonging to the type III region. (d) Icosahedron simulation for ka1¼ 102, kr1¼ 10, belonging to the type
I region. (e) Icosahedron simulation for ka1¼ 1, kr1¼ 102, belonging to the type II region. (f) Icosahedron simulation for ka1¼ 101, kr1¼ 101, belonging
to the type III region.
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effectively decoupling the octamer assembly pathway into
two distinct simpler reaction pathways acting on different
timescales: capsomer formation and dimerization of capso-
mers. Each of these pathways is protected from kinetic
trapping, the ﬁrst because none of its intermediates are stable
and the second because it has only a single step. By contrast,
the type III assembly is susceptible to kinetic trapping when
binding rates are high enough for its second-order elongation
rate to approach its fourth-order nucleation rate. The type I
assembly is always vulnerable to kinetic trapping because its
nucleation and elongation reactions have the same order and
thus comparable rates for any binding rates. For the
icosahedron, though, the answer is more complicated. The
type I domain appears to be optimal for achieving peak yield
at the highest assembly rate. Yet the type II domain’s lower
sensitivity to parameter variations may make it superior for
achieving a robustly high rate and yield under more
unpredictable assembly conditions. The nonhierarchical
type III domain achieves a balance between these two
tradeoffs, with border regions between the domains provid-
ing further room to tune the characteristics to particular
assembly conditions. This observation might explain why
the natural virology world appears to offer examples of all
three kinds of assembly; the ‘‘best’’ domain could be any of
the three or anywhere in between, depending on how
predictable the assembly conditions are or what other
mechanisms are employed to make them more predictable.
This observation leads to a second question: where might
actual capsid assembly systems sit in this phase space? The
prior literature provides some approximate estimates of the
free energy of binding during capsid assembly. Model-based
inferences from experimental data establish a range from
;2.9 to 4.4 kcal/mol per contact for HBV assembly (29)
and ;3.8 kcal/mol, including coat and scaffold contribu-
tions, for P22 assembly (30). If we use 3.8 kcal/mol per
contact as a consensus value, that would imply that the ratio
k1/k is;680 M
1 at 20C for each binding site. Where this
value would map on our phase diagrams depends on what we
assume the units of concentration of our simulations to be,
using an equivalence theorem sketched out in a previous
study (8). If we assume our simulations represent 10 mM, a
typical concentration for in vitro capsid assembly, then the
k1/k needed to yield a free energy of 3.8 kcal/mol would
be 8.5 3 106 particle1 for the octamer system or 1.1 3
106 particle1 for the icosahedron system. We can thus
very roughly map real capsid assembly rates to this phase
space by assuming ka1/ka ¼ kr1/kr  8.5 3 106
particle1 for the octamer and ka1/ka ¼ kr1/kr  1.1 3
106 particle1 for the icosahedron system. Fig. 5 identiﬁes
the corresponding points (represented with circles) in the
parameter spaces for the two systems. For the octamer
assembly, the consensus point lies in the middle of the type
III nonhierarchical region. Our rate estimates would need to
be perturbed by ;3 orders of magnitude in either parameter
(DDG  4.0 kcal/mol) to produce hierarchical assembly by
either mechanism. For the icosahedron, on the other hand,
the consensus point lies approximately on the boundary of
the type I and type III regions. Only a small error in either
rate estimate would be needed to push it clearly into the type
I or type III regions. A change of ;2 orders of magnitude
(DDG  2.7 kcal/mol) in either parameter would be needed
to produce type II assembly.
Our conclusions are very different if we assume our
simulation represents a concentration of 500 mM, a level
likely to be unachievable in vitro but realistic for the local
concentration of coat protein at sites of capsid assembly in
vivo (30). A free energy of binding 3.8 kcal/mol would
then imply k1/k ¼ 4.3 3 104 particle1 for the octamer
and k1/k ¼ 5.7 3 105 particle1 for the icosahedron. For
the octamer, assuming ka1/ka ¼ kr1/kr ¼ 4.3 3 104
particle1 would still produce type III assembly with nearly
complete yield, although the rate would be increased ;50-
fold relative to the 10-mM concentration. For the icosahe-
dron, though, the higher concentration would move the
system from the border of type I and type III domains well
into the type III domain. These points are marked by squares
in Fig. 5. The concentration change from the in vitro to the in
vivo range would thus result in a substantial shift in the
favored assembly pathways of the system. A slight loss in
yield but a sizeable increase in rate would accompany the
change in overall assembly pathway.
In drawing conclusions from such a simulation study, we
must ask how the observed results might have been biased by
the limitations of the model. The stochastic simulation
method we used assumes a uniform reaction space in which
times between reaction events are sufﬁciently long that
spatial arrangements of particles can be assumed random.
These assumptions are shared by ordinary differential
equation (ODE) models of capsid assembly (17,31) but not
required by Brownian dynamics capsid assembly models
(1,9,20,27) or spatial Monte Carlo models (32). It is not
possible to directly duplicate this study with any of these
spatially aware models because all of them either used
smaller symmetric 20-mer capsid models that cannot exhibit
the hierarchical pathways of interest to us (20,32) or required
concentrations above typical in vitro (1,20) or even in vivo
levels (9,27,28) for systems to approach completion in
reasonable timescales. We must therefore extrapolate from
studies of simpler assembly systems to judge under what
conditions explicit consideration of spatial arrangements of
assemblies would lead to signiﬁcant differences in quanti-
tative performance. This question has been extensively
studied in the literature on modeling macromolecular
crowding effects on assembly reactions. These studies have
suggested that models explicitly accounting for spatial
effects will produce results virtually identical to space-
independent ODE models under low concentration condi-
tions, where particle diffusion is relatively unimpeded and
long times elapse between collisions, but that the two will
markedly diverge under conditions of high concentration.
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See, for example, Minton (33,34) and Zimmerman and
Minton (35) for reviews of this issue. Models of other
assembly systems suggest that a divergence between space-
independent and space-free models will occur between
typical in vitro and in vivo concentrations. For example,
hard-sphere models of sickle-cell hemoglobin polymeriza-
tion have suggested a modest 7% deviation from idealized
space-free models at 20 g/L (1.25 mM) HbS, with the
deviation rapidly increasing with higher concentrations.
Space-aware lattice models of actin-like ﬁlament assembly
suggested an ;10% deviation from idealized kinetics at 250
mM, with a rapid increase beyond that point (36,37). We can
therefore suggest that simulations of in vitro capsid assembly
systems are unlikely to be signiﬁcantly quantitatively altered
by the lack of an explicit spatial model. This conclusion is
supported by the fact that Zlotnick et al. (10) achieved a
high-quality ﬁt to a hepatitis B assembly system with their
space-free ODE model over a broad range of in vitro
concentrations and solution conditions.
Conclusions about results at in vivo concentrations where
crowding effects become signiﬁcant may be less trustworthy,
especially if we account for the general crowding of the cell
in addition to the higher concentration of coat monomers in
vivo. Macromolecular crowding is generally observed to
enhance assembly reactions (33) and crowding agents have
been successfully used to promote assembly in several
capsid assembly systems (38–41). We can therefore suggest
that the shift our model predicts between in vitro to in vivo
conditions in Fig. 5 is likely to understate the true magnitude
of the change in rates and, thus, in pathways due to high
concentrations of capsid proteins themselves and due to
generalized crowding in the cell environment. Although one
can in principle correct for crowding effects in an idealized
model by adjusting rate constants (35), there is no general
way to determine the amount of adjustment from ﬁrst prin-
ciples. These extremely high concentrations happen to be
precisely where Brownian capsid assembly models become
computationally tractable, and we might therefore suggest
that the two model types might be treated as complementary
sources of information, each more appropriate for modeling
certain parameter domains.
A related issue in considering the reliability of our model
is the fact that it excludes the possibility of malformed
growth, which might lead to trapped malformed states or to
rate changes due to reversible unproductive assembly.
Whether this limitation is problematic depends on the degree
to which off-pathway assembly occurs in the reaction system
modeled. We are unaware of any attempt to quantify in vivo
accuracy of assembly of any virus under normal conditions
of host infection, but anecdotal evidence suggests assembly
malformations are rare in wild-type conditions. Accuracy for
in vitro systems depends a great deal on the system and the
speciﬁc assembly conditions. For example, Zlotnick et al.
(42) report no detection of misassembled forms in hepatitis B
virus under ideal in vitro conditions whereas Moore and
Prevelige (43) report only a minimal (but not quantiﬁed)
fraction of misassembled species in a phage P22 in vitro
assembly system. These and other capsids can produce high
degrees of malformed growth under a variety of artiﬁcial
conditions, including absence of key scaffold proteins
(41,44), unusual ion concentrations during assembly (10),
or changes in the stoichiometry of other assembly factors
(43). Other in vitro systems, such as those for phage P4 (39)
and phage f29 (41), produce a large fraction of malformed
species. The lack of a malformation mechanism in our study
might be expected to lead to overestimates of yield and
possibly assembly rate if it is applied to a system with an
appreciable fraction of malformed structures. Our space-
independent stochastic model can allow for exploration of
malformed states (19), but with a much more computation-
ally intensive method that would also be infeasible for this
study.
Brownian models and similar discretized spatial Monte
Carlo models also provide a straightforward way to simulate
malformed growth, a capability used by Schwartz et al.
(1,45), Hagan and Chandler (9), Nguyen et al. (20), andWilber
et al. (32), but are again also computationally infeasible for
much of the parameter domains of interest in this study. We
can, nonetheless, use the results of these other models to
estimate where and how the conclusions of this study might
be compromised by the lack of a malformation model.
Schwartz et al. (1), Hagan and Chandler (9), and Wilber et al.
(32) all found that malformed structures became the
dominant assembly type under conditions of high concen-
tration, but the exact amount depended on other parameters
approximately corresponding to the energy of attraction of
binding sites and the geometric ﬂexibility of binding. All
found malformations dominant with their default binding
parameters only for concentrations in millimolar ranges,
assuming a 4-nm particle in the case of Wilber et al. (32).
With the most permissive binding parameters, though,
malformations could become prominent at concentrations
as low as 250 mM for Schwartz et al. (1). Nguyen et al. (20)
had similarly found that with sufﬁciently strong binding
interactions (low temperature), misassembled structures
could become a common species across a wide range of
concentrations, although malformed structures were never
the dominant species in the 5.41- to 173-mM parameter range
they examined. They further found, though, that tempera-
tures yielding predominantly misassembled structures were
strictly separated from those yielding predominantly com-
plete assemblies by a wide region of kinetic trapping. Their
results would appear to suggest that malformed growth
competes with kinetically trapped growth and not with
productive growth. We can therefore suggest that the lack of
malformation pathways in our model is likely to lead
to inaccurate assembly kinetics only within a subset of
the kinetically trapped region of our parameter space
corresponding to exceptionally high rates or concentrations.
This region might extend more widely if coat-coat binding
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interactions are signiﬁcantly stronger or more ﬂexible than
past capsid assembly models have assumed.
Finally, our use of a model that assumes inﬁnite stability
for structures held together by multiple binding interactions
will limit the range of parameters in which the model is
applicable. Experimental evidence from phage P22 (30,46)
suggests that monomers exchange with free coat protein,
allowing eventual equilibration of kinetically trapped states.
This equilibration occurs on a timescale of weeks, however,
in contrast to the timescale of minutes of the assembly
process itself. Inﬁnite loop stability would therefore be
expected to have little impact on simulations such as those
presented here that track the assembly process over the time
required to exhaust free monomers. The assumption would
not be valid for simulations several orders of magnitude
longer, however, that attempted to capture the equilibration
process of these kinetically trapped forms. Likewise, the
assumption of inﬁnite stability would become problematic
for simulations run close to the critical concentration of
capsid assembly, where the nucleation rate is comparable to
the reverse rate of looped structures. Estimates in the litera-
ture for critical concentrations of capsid assembly systems
are highly variable depending on solvent conditions and
availability of auxiliary scaffolding molecules, but vary ap-
proximately from a low of;2 mM for CCMV (47) to a high
of ;5–6 mM for phage P22 with excess scaffold (30,46,5).
The slowest simulations presented here correspond to con-
centrations approximately an order of magnitude above these
estimates, suggesting that the assumption of inﬁnite loop
stability should have a minor effect on the most extreme
points in our parameter space and a negligible effect else-
where. This assumption would become problematic if we
were to expand these simulations to lower rates, comparable
to or below likely critical concentrations.
These analyses lead to several general conclusions about
our ability to understand capsid assembly, whether by
theory, simulation, or in vitro experiments. First, results from
in vitro model systems may not be reliable guides to the
pathways in use in the in vivo system. Although it is well
established from theoretical and experimental studies that in
vitro viral assembly systems can transition between produc-
tive and kinetically trapped domains within feasible in vitro
concentration ranges (1,10,8,30,48), our results go further to
say that feasible changes in concentration between in vitro
and in vivo systems could produce transitions between
entirely different productive pathways. As noted above, our
model may in fact understate the magnitude of these shifts
because of its neglect of spatial crowding effects on
assembly rates. Second, results from simple model systems
on the scale of the octamer may substantially mislead us
about more complex systems, even an icosahedron repre-
senting only the simplest T ¼ 1 spherical capsids. The
icosahedral system exhibits much greater parameter sensi-
tivity in rate, yield, and choice of assembly pathways. Thus,
a change in assembly conditions corresponding to 50-fold
concentration increase can produce a substantial change in
pathways and assembly rate for the icosahedron while
producing only modest changes in rate and no change in
pathways or yield for the octahedron. These effects of system
size on pathway control are consistent with prior modeling
work showing that several unexpected qualitative properties
of capsid-like assembly become apparent only with rela-
tively complex models (19). Third, our theoretical tools for
understanding these systems provide an incomplete picture
that is reasonable only for limited portions of the parameter
space. Our theory is best developed for understanding the
type III domain, which is well described by tools of classic
nucleation theory (49). Much of the actual parameter
domain, though, is occupied by hierarchical mechanisms
that are more difﬁcult to model theoretically. Even those
hierarchical models simplify the true picture considerably, as
a large part of the parameter space appears not to lie cleanly
in any of these three discrete domains, but rather to lie in
boundary regions that are even more poorly described by
existing theory. Furthermore, even a single system can tran-
sition between these domains in response to modest changes
in parameter values or assembly conditions. Collectively,
these observations suggest that we may not know nearly as
much as we think we do about complex self-assembly.
Neither our theoretical models, nor our knowledge from
simple model systems, nor even our experimental studies of
capsid assembly in vitro can necessarily be relied upon to
characterize complex capsid assembly in vivo. Addressing
these problems will likely require new theory, improved sim-
ulations, and new experimental methods for probing com-
plex reactions in vivo or better mimicking in vivo conditions
in vitro.
REFERENCES
1. Schwartz, R., P. W. Shor, P. E. Prevelige, Jr., and B. Berger. 1998.
Local rules simulation of the kinetics of virus capsid self-assembly.
Biophys. J. 75:2626–2636.
2. Kelly, J. W. 1998. The environmental dependency of protein folding
best explains prion and amyloid diseases. Proc. Natl. Acad. Sci. USA.
95:930–932.
3. Baskakov, I. V., C. Aagaard, I. Mehlhorn, H. Wille, D. Groth, M. A.
Baldwin, S. B. Prusiner, and F. E. Cohen. 2000. Self-assembly of recom-
binant prion protein of 106 residues. Biochemistry. 39:2792–2804.
4. Forster, A. C., and G. M. Church. 2006. Towards synthesis of a
minimal cell. Mol. Syst. Biol. 2:45.
5. Prevelige, P. E., D. Thomas, and J. King. 1993. Nucleation and growth
phases in the polymerization of coat and scaffolding subunits into
icosahedral procapsid shells. Biophys. J. 64:824–835.
6. Xie, Z. H., and R. W. Hendrix. 1995. Assembly in vitro of
bacteriophage HK97 proheads. J. Mol. Biol. 253:74–85.
7. Casini, G. L., D. Graham, D. Heine, R. L. Garcea, and D. T. Wu. 2004.
In vitro papillomavirus capsid assembly analyzed by light scattering.
Virology. 325:320–327.
8. Zhang, T., and R. Schwartz. 2006. Simulation study of the contribution
of oligomer/oligomer binding to capsid assembly kinetics. Biophys. J.
90:57–64.
9. Hagan, M. F., and D. Chandler. 2006. Dynamic pathways for viral
capsid assembly. Biophys. J. 91:42–54.
782 Sweeney et al.
Biophysical Journal 94(3) 772–783
10. Zlotnick, A., J. M. Johnson, P. W. Wingﬁeld, S. J. Stahl, and D.
Endres. 1999. A theoretical model successfully identiﬁes features of
hepatitis B virus capsid assembly. Biochemistry. 38:14644–14652.
11. Zlotnick, A., R. Aldrich, J. M. Johnson, P. Ceres, and M. J. Young.
2000. Mechanism of capsid assembly for an icosahedral plant virus.
Virology. 277:450–456.
12. Prevelige, P. E., Jr. 1998. Inhibiting virus-capsid assembly by altering
the polymerisation pathway. Trends Biotechnol. 16:61–65.
13. Stray, S. J., C. R. Bourne, S. Punna, W. G. Lewis, M. G. Finn, and
A. Zlotnick. 2005. A heteroaryldihydropyrimidine activates and can
misdirect hepatitis B virus capsid assembly. Proc. Natl. Acad. Sci.
USA. 102:8138–8143.
14. Sticht, J., M. Humbert, S. Findlow, J. Bodem, B. Muller, U. Dietrich,
J. Werner, and H. G. Krausslich. 2005. A peptide inhibitor of HIV-1
assembly in vitro. Nat. Struct. Mol. Biol. 12:671–677.
15. Whitesides, G. M., and B. Grzybowski. 2002. Self-Assembly at all
scales. Science. 295:2418–2421.
16. Zhang, S. 2003. Fabrication of novel biomaterials through molecular
self-assembly. Nat. Biotechnol. 21:1171–1178.
17. Endres, D., M. Miyahara, P. Moisant, and A. Zlotnick. 2005. A reaction
landscape identiﬁes the intermediates critical for self-assembly of virus
capsids and other polyhedral structures. Protein Sci. 14:1518–1525.
18. Keef, T., C. Micheletti, and R. Twarock. 2006. Master equation
approach to the assembly of viral capsids. J. Theor. Biol. 242:713–721.
19. Zhang, T., W. Kim, and R. Schwartz. 2007. Investigating scaling
effects on virus capsid-like self-assembly using discrete event simu-
lations. IEEE Trans. Nanobioscience. 6:235–241.
20. Nguyen, H. D., V. S. Reddy, and C. L. Brooks. 2007. Deciphering the
kinetic mechanism of spontaneous self-assembly of icosahedral
capsids. Nano Lett. 7:338–344.
21. Zhang, T., R. Rohlfs, and R. Schwartz. 2005. Implementation of a dis-
crete event simulator for biological self-assembly systems. Proceedings
of the 2005 Winter Simulation Conference, Orlando, FL. 2223–2231.
22. Gillespie, D. T. 1977. Exact stochastic simulation of coupled chemical
reactions. J. Phys. Chem. 81:2340–2361.
23. Bortz, A. B., M. H. Kalos, and J. L. Lebowitz. 1975. A new algorithm
for Monte-Carlo simulation of Ising spin systems. J. Comput. Phys.
17:10–18.
24. Jamalyaria, F., R. Rohlfs, and R. Schwartz. 2005. Queue-based method
for efﬁcient simulation of biological self-assembly systems. J. Comput.
Phys. 204:100–120.
25. Berger, B., P. W. Shor, L. Tucker-Kellogg, and J. King. 1994. Local
rule-based theory of virus shell assembly. Proc. Natl. Acad. Sci. USA.
91:7732–7736.
26. Lok, L., and R. Brent. 2005. Automatic generation of cellular reaction
networks with Moleculizer 1.0. Nat. Biotechnol. 23:131–136.
27. Rapaport, D., J. Johnson, and J. Skolnick. 1999. Supramolecular self-
assembly: molecular dynamics modeling of polyhedral shell formation.
Comput. Phys. Commun. 122:231–235.
28. Rapaport, D. C. 2004. Self-assembly of polyhedral shells: a molecular
dynamics study. Phys. Rev. E. 70:051905.
29. Ceres, P., and A. Zlotnick. 2002. Weak protein-protein interactions are
sufﬁcient to drive assembly of hepatitis B virus capsids. Biochemistry.
41:11525–11531.
30. Parent, K. N., A. Zlotnick, and C. M. Teschke. 2006. Quantitative
analysis of multi-component spherical virus assembly: scaffolding
protein contributes to the global stability of phage P22 procapsids.
J. Mol. Biol. 359:1097–1106.
31. Zlotnick, A. 1994. To build a virus capsid—an equilibrium model
of the self-assembly of polyhedral protein complex. J. Mol. Biol. 241:
59–67.
32. Wilber, A. W., J. P. K. Doye, A. A. Louis, E. G. Noya, M. A. Miller,
and P. Wong. 2007. Reversible self-assembly of patchy particles into
monodisperse icosahedral clusters. J. Chem. Phys. In press.
33. Minton, A. P. 2000. Implications of macromolecular crowding for
protein assembly. Curr. Opin. Struct. Biol. 10:34–39.
34. Minton, A. P. 2006. How can biochemical reactions within cells differ
from those in test tubes? J. Cell Sci. 119:2863–2869.
35. Zimmerman, S. B., and A. P. Minton. 1993. Macromolecular
crowding: biochemical, biophysical, and physiological consequences.
Annu. Rev. Biophys. Biomol. Struct. 22:27–65.
36. Puskar, K., S. Ta’asan, R. Schwartz, and P. R. LeDuc. 2006.
Evaluating spatial constraints in cellular assembly processes using a
Monte Carlo approach. Cell Biochem. Biophys. 45:195–201.
37. Puskar, K., L. Apeltsin, S. Ta’asan, R. Schwartz, and P. R. LeDuc.
2004. Understanding actin organization in cell structure through lattice
based Monte Carlo simulations. Mech. Chem. Biosyst. 1:123–131.
38. Cerritelli, M. E., and F. W. Studier. 1996. Assembly of T7 capsids
from independently expressed and puriﬁed head protein and scaffold-
ing protein. J. Mol. Biol. 258:286–298.
39. Wang, S., P. Palasingam, R. H. Nokling, B. H. Lindqvist, and T.
Dokland. 2000. In vitro assembly of bacteriophage P4 procapsids from
puriﬁed capsid and scaffolding proteins. Virology. 275:133–144.
40. del Alamo, M., G. Rivas, and M. G. Mateu. 2005. Effect of
macromolecular crowding agents on human immunodeﬁciency virus
type 1 capsid protein assembly in vitro. J. Virol. 79:14271–14281.
41. Fu, C. Y., M. C. Morais, A. J. Battisti, M. G. Rossmann, and P. E.
Prevelige, Jr. 2007. Molecular dissection of f29 scaffolding protein
function in an in vitro assembly system. J. Mol. Biol. 366:1161–1173.
42. Zlotnick, A., P. Ceres, S. Singh, and J. M. Johnson. 2002. A small
molecule inhibits and misdirects assembly of hepatitis B virus capsids.
J. Virol. 76:4848–4854.
43. Moore, S. D., and P. E. Prevelige Jr. 2002. Bacteriophage P22 portal
vertex formation in vivo. J. Mol. Biol. 315:975–994.
44. Earnshaw, W., and J. King. 1978. Structure of phage P22 coat protein
aggregates formed in the absence of the scaffolding protein. J. Mol.
Biol. 126:721–747.
45. Schwartz, R., P. E. Prevelige Jr., and B. Berger. 1998. Local Rules
Modeling of Nucleation-Limited Virus Capsid Assembly. MIT Lab-
oratory for Computer Science, Massachusetts Institute of Technology,
Cambridge, MA.
46. Parent, K. N., M. M. Suhanovsky, and C. M. Teschke. 2007. Phage
P22 procapsids equilibrate with free coat protein subunits. J. Mol. Biol.
365:513–522.
47. Endres, D., and A. Zlotnick. 2002. Model-based analysis of assembly
kinetics for virus capsids or other spherical polymers. Biophys. J.
83:1217–1230.
48. Stray, S. J., P. Ceres, and A. Zlotnick. 2004. Zinc ions trigger
conformational change and oligomerization of hepatitis B virus capsid
protein. Biochemistry. 43:9989–9998.
49. Zandi, R., P. van der Schoot, D. Reguera, W. Kegel, and H. Reiss. 2006.
Classical nucleation theory of virus capsids. Biophys. J. 90:1939–1948.
Parameter Space of Capsid Self-Assembly 783
Biophysical Journal 94(3) 772–783
